Clinical Trial Results: Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer [NA]

View source ↗

Summary

Results from a completed study evaluating iBreast, a handheld device for detecting breast abnormalities during screening visits for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Breast Screening

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Screening | NA | Status: COMPLETED | Results posted: 2026-07-30